HomeInsightsMarket Capitalization

Market Capitalization of Wockhardt Ltd

Market Capitalization of Wockhardt Ltd

stocks purchased

₹ 2.5 Cr

Volume transacted

stocks purchased

26.4 K

stocks traded

Last Updated time: 10 Oct 15:30 PM

Image

Wockhardt Ltd

NSE: WOCKPHARMA

MARKETCAP

14537.09 crore

Last updated: 10 Oct 24

Key Highlights

  • The Market Cap of Wockhardt Ltd is ₹ 14537 crore as of 10 Oct 24.
  • The Market Cap of Wockhardt Ltd changed from ₹ 4903 crore on March 2019 to ₹ 8951 crore on March 2024 . This represents a CAGR of 10.55% over 6 years. .
  • The Latest Trading Price of Wockhardt Ltd is ₹ 947.6 as of 10 Oct 15:30.

Historical Market Cap of Wockhardt Ltd

No data available

* All values are in crore

Company Fundamentals for Wockhardt Ltd

No data available

Image

Wockhardt Ltd

NSE: WOCKPHARMA

PRICE

947.6

-14.55 (-1.51%)

stock direction

Last updated: 10 Oct 15:30

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Wockhardt Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
10 Oct 2024947.6
09 Oct 2024962.15
08 Oct 2024956.6
07 Oct 2024949.4
04 Oct 2024972.3
03 Oct 2024963.6
01 Oct 2024962.3
30 Sep 2024981.9
27 Sep 2024988.45
26 Sep 2024993.15

SWOT Analysis Of Wockhardt Ltd

Strength

3

S

Weakness

1

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Wockhardt Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Wockhardt Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Wockhardt Ltd014,537
Sun Pharmaceuticals Industries Ltd424,52,850
Divis Laboratories Ltd941,57,702
Cipla Ltd291,30,709
Torrent Pharmaceuticals Ltd691,16,560
Dr Reddys Laboratories Ltd191,09,846

Key Valuation Metric of Wockhardt Ltd

No data available

Historical P/E Ratio of Wockhardt Ltd

No data available

* All values are in %

Historical Revenue of Wockhardt Ltd

No data available

* All values are in crore

Historical EBITDA of Wockhardt Ltd

No data available

* All values are in crore

Historical Net Profit of Wockhardt Ltd

No data available

* All values are in crore

Historical Dividend Payout of Wockhardt Ltd

No data available

* All values are in %

About Wockhardt Ltd

  • Wockhardt Limited is a global pharmaceutical and biotechnology organization, providing affordable, high-quality medicines for a healthier world.
  • The Company is India's leading research-based global healthcare enterprise in fields of Pharmaceuticals, Biotechnology and a chain of advanced Super Speciality Hospitals.
  • It has 12 manufacturing locations and there are 3 locations where research and development activities are carried out. The Company has manufacturing and research facilities in India, USA & UK and a manufacturing facility in Ireland.
  • It has a significant presence in USA, Europe and India, with 83% of its global revenues coming from international businesses.
  • Wockhardt is the only company in the world where USFDA has given QIDP Status (Qualified lnfectious Diseases Programme) for 5 of Anti-bacterial discovery programmes - 2 of them are Gram Negative and 3 Gram Positive effective against untreatable 'Superbugs'.

Wockhardt Ltd News Hub

News

Wockhardt's once-a-day antibiotic drug 'WCK 6777' successfully concludes Phase I study

Wockhardt is advancing the development of several new antibiotics aimed at combating diffi...

Read more

07 Oct 202414:59

News

Wockhardt announces cessation of director

Wockhardt announced that Tasneem Vikram Singh Mehta (DIN: 05009664) ceased to be Independe...

Read more

30 Sep 202418:20

News

Wockhardt's investigational drug, Zaynich' demonstrates its ability to manage complex infections

In the past year, Wockhardt's investigational drug, Zaynich' (Zidebactam/Cefepime), has su...

Read more

19 Sep 202409:15

News

Wockhardt allots 8,610 equity shares under ESOS

Wockhardt has allotted 8,610 equity shares under ESOS in 26 August 2024. With this allotme...

Read more

26 Aug 202417:00

News

Wockhardt to table results

Wockhardt will hold a meeting of the Board of Directors of the Company on 9 August 2024. P...

Read more

08 Aug 202410:21

News

Wockhardt soars as Zaynich shows promise against superbugs

A young cancer patient with a chronic thigh infection caused by a very resistant bacteria ...

Read more

01 Jul 202410:01

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Market Cap of Wockhardt Ltd

What is the market cap of Wockhardt Ltd?

As of October 10, 2024, Wockhardt Ltd has a market capitalization of ₹14537.09, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Wockhardt Ltd's market capitalization?

Wockhardt Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Wockhardt Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Wockhardt Ltd's market capitalization change?

Wockhardt Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*